Evidence that elevated lipoprotein (a)(Lp [a]) levels contribute to cardiovascular disease
(CVD) and calcific aortic valve stenosis (CAVS) is substantial. Development of isoform …

Lipoprotein (a)[Lp (a)] has attracted the interest of researchers and physicians due to its
intriguing properties, including an intragenic multiallelic copy number variation in the LPA …

Abstract Background: Elevated lipoprotein (a)(Lp [a]) is associated with aortic stenosis (AS).
Oxidized phospholipids (OxPL) are key mediators of calcification in valvular cells and are …

Epidemiological and clinical studies over the past decade have firmly established that
elevated plasma concentrations of lipoprotein (a)(Lp (a)) are an important, independent and …

Atherosclerosis is a life-long illness that begins with risk factors, which in turn contribute to
the development of subclinical disease, followed by the establishment of overt …

Lipoprotein(a) Concentration and the Risk of Coronary Heart Disease, Stroke, and Nonvascular
Mortality - PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI Homepage …

Plasma lipoprotein (a)[L p (a)] is a quantitative genetic trait with a very broad and skewed
distribution, which is largely controlled by genetic variants at the LPA locus on chromosome …

Context The value of assessing various emerging lipid-related markers for prediction of first
cardiovascular events is debated. Objective To determine whether adding information on …

Glycerophospholipids represent a common class of lipids critically important for integrity of
cellular membranes. Oxidation of esterified unsaturated fatty acids dramatically changes …

The oxidative modification hypothesis of atherosclerosis, which assigns to oxidized low‐
density lipoproteins (LDLs) a crucial role in atherosclerosis initiation and progression, is still …